The trial was designed based on results from the earlier phase 2 study of ataciguat ( NCT02481258 ), which failed to reach statistical significance due to a small sample size and limited follow-up duration [ 71 ].
← all excerpts
Calcific Aortic Valve Disease: Mechanism and Future Therapeutic Strategies.
1
—
—